AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2014
Aug 15, 2014
35124_dirs_2014-08-15_03e23ef0-dab1-4fb9-9a97-f1ea12069a84.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2014-08-15
Reporting Person: Tardugno Michael H (CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-08-15 | Celsion Corporation Common Stock | P | 4000 | $3.119 | Acquired | 74521 | Direct |
Footnotes
F1: The Officer purchased the shares on the open market
F2: The number of Shares the Officer beneficially owned is 74,521 after the purchase of 4,000 shares of stock purchase on August 15, 2014
More from Imunon, Inc.
Board/Management Information
2026
Jun 30
Call Transcript
2026
Jun 25
Regulatory Filings
2026
Jun 17
Board/Management Information
2026
Jun 16
Call Transcript
2026
Jun 16
Capital/Financing Update
2026
Jun 4
Regulatory Filings
2026
May 12
Call Transcript
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12